PTEN and prostate cancer: The discrepancies in the published data concerning the role of PTEN in HR can be attributed to the fact that PTEN loss is a late event during carcinogenesis (e.g. in prostate cancer)28, suggesting that additional genomic alterations may occur in a PTEN-independent manner which might mask the role of PTEN in HR.